Daniele Cretella

1.4k total citations
26 papers, 1.1k citations indexed

About

Daniele Cretella is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Daniele Cretella has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Daniele Cretella's work include Lung Cancer Treatments and Mutations (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Advanced Breast Cancer Therapies (6 papers). Daniele Cretella is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Advanced Breast Cancer Therapies (6 papers). Daniele Cretella collaborates with scholars based in Italy, Netherlands and United States. Daniele Cretella's co-authors include Andrea Cavazzoni, Pier Giorgio Petronini, Roberta Alfieri, Claudia Fumarola, Silvia La Monica, Mara Bonelli, Graziana Digiacomo, Marcello Tiseo, Maricla Galetti and Andrea Ardizzoni and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Daniele Cretella

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniele Cretella Italy	23	714	574	466	181	105	26	1.1k
Nicolas Floc’h United Kingdom	14	464 0.6×	493 0.9×	587 1.3×	223 1.2×	102 1.0×	30	1.2k
Gareth Hughes United Kingdom	13	627 0.9×	321 0.6×	694 1.5×	266 1.5×	61 0.6×	22	1.3k
Julia Rotow United States	14	609 0.9×	654 1.1×	582 1.2×	316 1.7×	70 0.7×	47	1.1k
Haitian Quan China	17	662 0.9×	383 0.7×	492 1.1×	137 0.8×	62 0.6×	30	1.3k
Gunnar Schütz Germany	9	530 0.7×	333 0.6×	353 0.8×	150 0.8×	52 0.5×	15	1.2k
Philip Bonomi United States	15	593 0.8×	403 0.7×	592 1.3×	120 0.7×	112 1.1×	37	1.2k
Elena Galvani Italy	16	585 0.8×	276 0.5×	459 1.0×	290 1.6×	199 1.9×	38	1.0k
Christelle Bonnetaud France	16	779 1.1×	446 0.8×	449 1.0×	618 3.4×	167 1.6×	32	1.4k
Emmy D.G. Fleuren Netherlands	17	368 0.5×	307 0.5×	497 1.1×	108 0.6×	76 0.7×	25	871
J. Rafael Sierra United States	11	364 0.5×	249 0.4×	582 1.2×	133 0.7×	195 1.9×	18	1.1k

Countries citing papers authored by Daniele Cretella

Since Specialization

Citations

This map shows the geographic impact of Daniele Cretella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Cretella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Cretella more than expected).

Fields of papers citing papers by Daniele Cretella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Cretella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Cretella. The network helps show where Daniele Cretella may publish in the future.

Co-authorship network of co-authors of Daniele Cretella

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Cretella. A scholar is included among the top collaborators of Daniele Cretella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Cretella. Daniele Cretella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cavazzoni, Andrea, Graziana Digiacomo, Roberta Alfieri, et al.. (2020). Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers. 12(3). 666–666. 36 indexed citations

Digiacomo, Graziana, Claudia Fumarola, Silvia La Monica, et al.. (2020). Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines. Frontiers in Oncology. 10. 563249–563249. 25 indexed citations

Bonelli, Mara, Silvia Zoppi, Claudia Fumarola, et al.. (2020). Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells. International Journal of Molecular Sciences. 21(14). 5165–5165. 26 indexed citations

Monica, Silvia La, Roberta Minari, Daniele Cretella, et al.. (2019). Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion. Targeted Oncology. 14(5). 619–626. 38 indexed citations

Monica, Silvia La, Roberta Minari, Daniele Cretella, et al.. (2019). Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC. Journal of Experimental & Clinical Cancer Research. 38(1). 222–222. 54 indexed citations

Fumarola, Claudia, Riccardo Castelli, Francesca Ferlenghi, et al.. (2019). Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. Frontiers in Oncology. 9. 179–179. 36 indexed citations

Cretella, Daniele, Claudia Fumarola, Mara Bonelli, et al.. (2019). Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells. Scientific Reports. 9(1). 13014–13014. 62 indexed citations

Cretella, Daniele, Andrea Ravelli, Claudia Fumarola, et al.. (2018). The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells. Journal of Experimental & Clinical Cancer Research. 37(1). 72–72. 84 indexed citations

Corona, Silvia Paola, Andrea Ravelli, Daniele Cretella, et al.. (2017). CDK4/6 inhibitors in HER2-positive breast cancer. Critical Reviews in Oncology/Hematology. 112. 208–214. 37 indexed citations

10.

Rogolino, Dominga, Andrea Cavazzoni, Anna Gatti, et al.. (2017). Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands. European Journal of Medicinal Chemistry. 128. 140–153. 61 indexed citations

11.

Ravelli, Andrea, Giandomenico Roviello, Daniele Cretella, et al.. (2017). Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility. Tumor Biology. 39(4). 3726131102–3726131102. 68 indexed citations

12.

Bonelli, Mara, Graziana Digiacomo, Claudia Fumarola, et al.. (2017). Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. Neoplasia. 19(8). 637–648. 82 indexed citations

13.

Monica, Silvia La, Daniele Cretella, Mara Bonelli, et al.. (2017). Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines. Journal of Experimental & Clinical Cancer Research. 36(1). 174–174. 67 indexed citations

14.

Monica, Silvia La, Denise Madeddu, Marcello Tiseo, et al.. (2016). Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR- Activating Mutation. Journal of Thoracic Oncology. 11(7). 1051–1063. 60 indexed citations

15.

Bonelli, Mara, Andrea Cavazzoni, Francesca Saccani, et al.. (2015). Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. Molecular Cancer Therapeutics. 14(8). 1916–1927. 32 indexed citations

16.

Romeo, Agostino, Giuseppe Tarabella, Pasquale D’Angelo, et al.. (2015). Drug-induced cellular death dynamics monitored by a highly sensitive organic electrochemical system. Biosensors and Bioelectronics. 68. 791–797. 28 indexed citations

17.

Galetti, Maricla, Pier Giorgio Petronini, Claudia Fumarola, et al.. (2015). Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines. PLoS ONE. 10(11). e0141795–e0141795. 54 indexed citations

18.

Cretella, Daniele, Francesca Saccani, Federico Quaini, et al.. (2014). Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance. Molecular Cancer. 13(1). 143–143. 55 indexed citations

19.

Monica, Silvia La, Cristina Caffarra, Francesca Saccani, et al.. (2013). Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification. PLoS ONE. 8(10). e78656–e78656. 46 indexed citations

20.

Cavazzoni, Andrea, Roberta Alfieri, Daniele Cretella, et al.. (2012). Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines. Molecular Cancer. 11(1). 91–91. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact